Follow
CAR-T Cell therapy Lymphoma
Chimeric antigen receptor T (CAR-T) cells are immune cells that have been genetically engineered in a laboratory to display an artificial T cell receptor enabling them to target a specified protein more effectively. CAR-T cell therapy can be used to treat lymphoma by engineering cells attracted to the antigens, specific molecules expressed on lymphoma cells.
SEP 23, 2020 | 12:00 PM
B cells and tertiary lymphoid structures (TLS) promote immunotherapy response 1:00–1:30 pm PDT Presented By: Rafet Basar, MD...
OCT 05, 2016 | 10:30 AM
The immune system possesses significant cytotoxic potential. Stimulating natural immunity through vaccination has shown promising effects in some cancers; however, a number of barriers limit...